Wei He
122Patents
17h-index
188Co-inventors
89Inventor score
Filing activity: Nov 4, 1993 → Jul 22, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6180632A | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases | Chemistry; Metallurgy | 232 | Expired |
| US6482834B2 | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases | Chemistry; Metallurgy | 217 | Expired |
| US6245760A | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases | Chemistry; Metallurgy | 206 | Expired |
| US6528526B1 | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases | Chemistry; Metallurgy | 189 | Expired |
| US5538892A | Nucleic acids encoding a TGF-.beta. type 1 receptor | Chemistry; Metallurgy | 42 | Expired |
| US6500638B2 | Prostatic growth factor | Emerging Cross-Sectional Technologies | 30 | Expired |
| US6521227B1 | Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides | Human Necessities | 29 | Expired |
| US5786204A | Human prostatic specific reductase | Physics | 29 | Expired |
| US5994102A | Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides | Emerging Cross-Sectional Technologies | 29 | Expired |
| US7741356B2 | Compounds as opioid receptor modulators | Chemistry; Metallurgy | 27 | Active |
| US7282351B2 | Prostatic growth factor | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5547854A | DNA encoding a receptor for Mullerian inhibitory substance, misr1, and corresponding vectors, cells, probes, and recombinant methods | Chemistry; Metallurgy | 25 | Expired |
| US7786158B2 | Compounds as opioid receptor modulators | Chemistry; Metallurgy | 21 | Active |
| US8685990B2 | Pyrimidine compounds as delta opioid receptor modulators | Chemistry; Metallurgy | 19 | Active |
| US6010878A | Interleukin-1 .beta. converting enzyme like apoptotic protease-6 | Human Necessities | 19 | Expired |
| US8440658B2 | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 | Chemistry; Metallurgy | 18 | Active |
| US9700542B2 | Compounds as opioid receptor modulators | Chemistry; Metallurgy | 18 | Active |
| US8344011B2 | Compounds as opioid receptor modulators | Chemistry; Metallurgy | 15 | Active |
| US9717745B2 | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases | Human Necessities | 14 | Active |
| US8772325B2 | Compounds as opioid receptor modulators | Chemistry; Metallurgy | 13 | Active |
| US9644038B2 | Apolipoprotein nanodiscs with telodendrimer | Chemistry; Metallurgy | 11 | Active |
| US8609709B2 | Compounds as opioid receptor modulators | Chemistry; Metallurgy | 11 | Active |
| US6316193A | Rapid-screen cDNA library panels | Chemistry; Metallurgy | 11 | Expired |
| US9205076B2 | Compounds as opioid receptor modulators | Chemistry; Metallurgy | 11 | Active |
| US5629193A | Paraoxonase | Emerging Cross-Sectional Technologies | 8 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.